NY-COTY
1.8.2024 14:32:27 CEST | Business Wire | Press release
Calvin Klein, Inc., part of PVH Corp. [NYSE: PVH], and Calvin Klein Fragrances, a division of Coty Inc. [NYSE: COTY], today launch CK One Essence, an intensified, premium take on the iconic original scent that introduces a bold addition to the CK One fragrance portfolio. Launched 30 years after the introduction of the original CK One, the new CK One Essence pays homage to the original fragrance’s olfactive DNA and celebrates its cultural legacy, reaffirming its evolution from a groundbreaking fragrance in the ‘90s to a new icon for a new era.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731704922/en/
Calvin Klein Fragrances Introduces CK One Essence (Photo: Business Wire)
[the fragrance]
This is the new intensity: Explosive. Energetic. Captivating.
To lend new emotion to the original spirit of CK One, Calvin Klein once again called upon Master Perfumer Alberto Morillas of dms-firmenich – the perfumer behind the iconic original CK One fragrance – to formulate this fresh iteration. Amplified with double the concentration of the original eau de toilette for long-lasting, powerful freshness, CK One Essence modernizes the original juice’s defiant notes to create a new olfactory symbol of timeless unity.
Top notes open the fragrance with the bright facets and fruit-forward tonalities of vibrant Italian Bergamot, responsibly sourced from a family-owned farm in Calabria, and blood orange. The juice offers an energizing and explosive profile from the first spritz.
At the heart, a curated, high-quality selection of teas, including organic green tea, invigorates and brings a modern freshness.
To ground the base, Morillas used a specific musk upcycled from the paper industry, adding a rich and sensual warmth complemented by a woody, creamy sandalwood accord.
The resulting scent is equal parts fresh, pure and sensual—an everyday uniform for a new generation.
[the campaign]
For the debut of CK One Essence, Calvin Klein partnered with visionary creative Alasdair McLellan to introduce a cast empowered by their individuality and united by the rebellious spirit at the heart of the CK One franchise. Channeling the brand’s signature black-and-white portraiture, the campaign shows the cast moving dynamically in harmony, in contrast and with total energy to the anthemic synths of New Order’s “Blue Monday.” The resulting visuals highlight the sensuality, togetherness and unity intrinsic to the heritage of CK One and celebrate a generation at one with themselves and each other.
[the packaging]
Grounded in the simplicity of the original CK One screw-top flask, both the bottle and secondary packaging were reimagined with premium, environmentally-preferred finishes. The bottle features a removable pump and a translucent metallic finish which reveals the juice inside. Its secondary metallic carton highlights the luxe nature of the new fragrance’s ingredients.
Calvin Klein CK One Essence will be available starting August 1st, 2024.
Product line-up:
1.7 FL OZ 50 ml
3.4 FL OZ 100 ml
6.7 FL OZ 200 ml (April 2025)
[the legacy]
CK One, the world’s first gender inclusive fragrance, embodied the modern minimalism at the core of the Calvin Klein brand ethos when it was introduced 30 years ago.
Launched at Tower Records in 1994, the original CK One captured the zeitgeist with a bold, defiant, anti-perfume scent that channeled music, fashion and pop culture in a bottle. The fragrance’s groundbreaking campaign forecasted a seismic shift in billboard faces, featuring street-cast misfits, moody models and real young lovers. With its pioneering attitude of universality, CK One was the first of its kind: a fragrance for everyone.
CREDITS:
Perfumer: Alberto Morillas, Master Perfumer
Campaign Photographer: Alasdair McLellan
SOCIAL MEDIA: @calvinklein
About Calvin Klein:
Calvin Klein is one of the world’s leading global fashion lifestyle brands with a history of bold, non-conformist ideals that inform everything we do. Founded in New York in 1968, the brand’s minimalist and sensual aesthetic drives our approach to product design and communication, creating a canvas that offers the possibility of limitless self-expression. The Calvin Klein brands — CK Calvin Klein, Calvin Klein, Calvin Klein Jeans, Calvin Klein Underwear, and Calvin Klein Performance — are connected by the intention and purpose of elevating everyday essentials to globally iconic status. Each of the brands has a distinct identity and position in the retail landscape, providing us the opportunity to market a range of universally appealing products to domestic and international consumers with a variety of needs. Our products are underpinned by responsible design, high-quality construction, and the elimination of all unnecessary details. We strive for unique and dimensional pieces that continuously wear well and remain relevant season after season. Global retail sales of Calvin Klein products were approximately $9 billion in 2023.
Calvin Klein continues to solidify its position as an innovator of emerging digital platforms and modern marketing campaigns. PVH acquired Calvin Klein in 2003 and continues to oversee a focused approach to growing the brand’s worldwide relevance, presence, and long term growth.
About COTY Inc.
Coty is one of the world’s largest beauty companies with an iconic portfolio of brands across fragrance, color cosmetics, and skin and body care. Coty is the global leader in fragrance, and number three in color cosmetics. Coty’s products are sold in over 150 countries around the world. Coty and its brands are committed to a range of social causes as well as seeking to minimize its impact on the environment. For additional information about Coty Inc., please visit www.coty.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731704922/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vena Completes Acterys Acquisition to Accelerate Orchestrated Planning for the Microsoft Ecosystem26.3.2026 14:00:00 CET | Press release
The combination connects AI-driven financial and operational planning, analytics and execution across Microsoft Excel and Power BI, removing decision latency for Microsoft-centric enterprises. Vena, the AI-powered Orchestrated Performance Management platform purpose-built to fully amplify the Microsoft technology ecosystem, today announced it has completed its acquisition of Acterys, the leading Microsoft Power BI–based operational planning and app development platform. The move strengthens Vena’s Orchestrated Planning solution and begins phased integration of the two platforms. Modern enterprises are struggling to keep up with the volatility and dynamism of the markets they serve. Market drivers and signals shift rapidly, and the ability to assess, plan and execute with confidence and speed is more important than ever. These forces, combined with overwhelming data density and disparity, have created a new constraint: decision latency—the time between signal and action. As that gap wid
Nearly Half of Global C-Suites Plan U.S. Expansion Within 12 Months, as Supply Chain and Capital Access Drive Growth26.3.2026 14:00:00 CET | Press release
• 45% of C-level executives plan to establish a U.S. legal entity within the next 12 months; a further 27% say they will consider entry within two to three years • 65% cite supply chain or manufacturing efficiency as the primary driver for U.S. expansion • 88% identify federal and state tax reporting as the most burdensome area of U.S. compliance Nearly half (45%) of global C-suite leaders plan to establish a legal entity in the United States within the next 12 months, highlighting continued demand for access to the U.S. market. This finding from the latest research by CSC—the leading provider of global business administration and compliance solutions—demonstrates the U.S. continues to attract investment from around the world, even as companies face an increasingly complex regulatory landscape. CSC surveyed 300 C-level executives at large organizations headquartered in Europe, the U.K., Asia Pacific, and South America to examine global sentiment toward U.S. market entry, including expa
Lone Star Funds Completes Acquisition of Alliance Ground International26.3.2026 13:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has completed the acquisition of Alliance Ground International (“AGI”), a leading North American airport services provider. “We are excited to partner with the AGI management team to drive the business forward,” said Donald Quintin, Chief Executive Officer of Lone Star. “The company has a superior service offering and a track record of success across its integrated operations. We see opportunities to continue to invest in the business and its people to continue to grow its capabilities and ensure it remains best-in-class in delivering for the aviation industry.” “Today marks an important next step for AGI as we move forward in partnership with Lone Star,” said Jared Azcuy, Chief Executive Officer of AGI. “Our commitment to safety, reliability, and operational service excellence remains unchanged. This partnership strengthens our ability to deliver for our airline partners and reinforces that the
Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging26.3.2026 13:30:00 CET | Press release
The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4) modulator, met its primary endpoint and also demonstrated a statistically significant relationship between target engagement and clinical improvement in psoriasis and atopic dermatitis RLS-1496 is a first-in-class disease-modifying mechanism targeting pathological senescent cells that drive inflammaging and chronic degenerative diseases of aging A second study for RLS-1496 – a Phase 1b/2a study in actinic keratosis (precancerous skin lesions) – is underway in the United States, with completion expected later this year Rubedo CEO Frederick Beddingfield, III, MD, PhD, FAAD, to moderate panel on senescence and skin at the Dermatology Innovation Forum (DIF) during the American Academy of Dermatology (AAD) annual meeting on Thursday, March 26, at 1:05 pm MT in Denver Oral presentation of data accepted at the Society for Investigative Dermatology (SID) from May 13-16, 2026, in Chicago Rubedo L
GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe26.3.2026 13:30:00 CET | Press release
COMPASS is one of the largest public‑private partnerships under the European Union’s (EU) Innovative Health Initiative (IHI). The consortium aims to advance early detection and prediction of cardiotoxicity in cancer patients and cancer survivors. The initiative will leverage AI, advanced imaging, biomarkers, and integrated care pathways. GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of cardiovascular risks in cancer patients across Europe. COMPASS combines clinical excellence with novel healthcare technology, and with a total budget of €50.5 million and more than sixty partners, it is one of the largest public-private partnerships under the IHI. Cardiovascular diseases are rising sharply among cancer patients and survivors, driven both by the increasing prevalence of pre‑existing cardiovascular conditions at diagnosis and by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
